Lancet Respir Med, 2213-2600
Journal
Publications
- 2020
- Published
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial
Gary Middleton, Kristian Brock & Lucinda Billingham, Sep 2020, In: The Lancet Respiratory Medicine. 8, 9, p. 895-904 10 p.Research output: Contribution to journal › Article › peer-review
- 2019
- Published
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial
Sue Mallett & 19 others, , Jun 2019, In: The Lancet Respiratory Medicine. 7, 6, p. 523-532 10 p.Research output: Contribution to journal › Article › peer-review
- 2018
- Published
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.
& 99 others, , 5 Dec 2018, In: Lancet Respir Med. 7, 3, p. 227-238 12 p.Research output: Contribution to journal › Article › peer-review
- Published
COPD exacerbations: transforming outcomes through research
Elizabeth Sapey, 1 Mar 2018, In: The Lancet Respiratory Medicine. 6, 3, p. 172-174 3 p.Research output: Contribution to journal › Comment/debate › peer-review
- 2016
- Published
Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial
Rachel Jordan, Peymane Adab, Alice Sitch, Deirdre Blissett, Sue Jowett, Richard Riley, Martin Miller, Alice Turner, Kate Jolly, Shamil Haroon, Sheila Greenfield, Amanda Daley, KK Cheng & David Fitzmaurice, Sep 2016, In: The Lancet Respiratory Medicine. 4, 9, p. 720-30 11 p.Research output: Contribution to journal › Article › peer-review
- 2015
- Published
Reducing the health effect of particles from agriculture
Roy Harrison, Nov 2015, In: The Lancet Respiratory Medicine. 3, 11, p. 831-832Research output: Contribution to journal › Article › peer-review
- Published
A pooled analysis of 15,632 COPD patients comparing the GOLD 2007 and 2011 staging systems for COPD focused on mortality
Alice Turner & 7 others, , Jun 2015, In: The Lancet Respiratory Medicine. 3, 6, p. 443-450 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis
Sue Mallett, Feb 2015, In: The Lancet Respiratory Medicine. 3, 2, p. 139-49 11 p.Research output: Contribution to journal › Article › peer-review
- Published
Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study
Julian Bion & 19 others, , Jan 2015, In: The Lancet Respiratory Medicine. 3, 1, p. 53-60 8 p.Research output: Contribution to journal › Article › peer-review
- 2014
- Published
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
& 31 others, , May 2014, In: The Lancet Respiratory Medicine. 2, 5, p. 395-404 10 p.Research output: Contribution to journal › Article › peer-review